These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 5012543)

  • 41. [Therapeutic experience with the use of piritinol (Encephabol) in geriatrics].
    Romano F
    Minerva Med; 1970 Jun; 61(51):2875-7. PubMed ID: 5432045
    [No Abstract]   [Full Text] [Related]  

  • 42. [Clinical experiences with Cinnarizin (Stugeron) in the treatment of arteriosclerotic and post-traumatic psychosyndromes].
    Voina S
    Schweiz Rundsch Med Prax; 1970 Aug; 59(32):1165-70. PubMed ID: 5513338
    [No Abstract]   [Full Text] [Related]  

  • 43. [Ophthalmological use of bencyclane and ophthalmodynamometric recording of its effect on cerebral vessels].
    Födö V
    Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1450+. PubMed ID: 5536669
    [No Abstract]   [Full Text] [Related]  

  • 44. [Clinical trial of a delayed-action preparation of beta pyridyl-carbinol in vascular pathology].
    Warembourg H; Thery C
    Lille Med; 1970 Apr; 15(4 Suppl 3):599-602. PubMed ID: 5424406
    [No Abstract]   [Full Text] [Related]  

  • 45. [Experiences with Trental in peripheral circulatory disorders and cerebrovascular insufficiency (author's transl)].
    Schafé MK
    Munch Med Wochenschr; 1973 Oct; 115(40):1745-9. PubMed ID: 4801042
    [No Abstract]   [Full Text] [Related]  

  • 46. [Trial of a new central and peripheral vaso-regulator therapeutic agent: DF 69].
    Laveant-Hebrard C; Camus JP
    Therapeutique; 1970 Oct; 46(8):805-6. PubMed ID: 4989868
    [No Abstract]   [Full Text] [Related]  

  • 47. The treatment of intermittent claudication with betapyridyl carbinol over two years.
    Nye ER; Macbeth WA
    Atherosclerosis; 1973; 17(1):95-106. PubMed ID: 4696751
    [No Abstract]   [Full Text] [Related]  

  • 48. [Analysis of the pharmacodynamic properties of the nicotinic ester of 7-(2-hydroxyethyl)-theophylline. II. Cardiocirculatory effects in subjects with cerebral and peripheral angiopathies].
    De Gregorio G; Scaffidi L; Arcoraci A
    Cardiol Prat; 1971 Oct; 22(5):329-36. PubMed ID: 5136470
    [No Abstract]   [Full Text] [Related]  

  • 49. Drugs in geropsychiatry.
    Petrie WM; Ban TA
    Psychopharmacol Bull; 1978 Oct; 14(4):7-19. PubMed ID: 360264
    [No Abstract]   [Full Text] [Related]  

  • 50. Differential effects of trazodone in depressed, schizophrenic and geriatric patients.
    Ban TA; Lehmann HE; Amin M; Bronheim LA; Klingner A; Nair NP; Galvan L; Vergara L; Zoch C
    Int J Clin Pharmacol; 1974 Jan; 9(1):23-7. PubMed ID: 4593127
    [No Abstract]   [Full Text] [Related]  

  • 51. [Treatment of peripheral arterial insufficiency with inositol nicotinate (Hexanicit)].
    Hentzer E
    Nord Med; 1966 Sep; 76(38):1090-3. PubMed ID: 5918550
    [No Abstract]   [Full Text] [Related]  

  • 52. Preliminary results in the treatment of peripheral arteriopathies with a new pharmacologic substance: I-(2"pyrimidyl)4 piperonyl piperazine (ET 495).
    Royer RJ
    Bibl Cardiol; 1969; 26():174-9. PubMed ID: 5402343
    [No Abstract]   [Full Text] [Related]  

  • 53. [Therapy with Instenon in the psychiatric-geriatric practice].
    Hirschberg E
    Munch Med Wochenschr; 1969 Jan; 111(3):147-9. PubMed ID: 4388434
    [No Abstract]   [Full Text] [Related]  

  • 54. [Clinical ophthalmodynamographic results of the treatment of cerebral circulation disorders with O-(beta-hydroxyethyl)-rutoside].
    Tzavellas O
    Arzneimittelforschung; 1970 Sep; 20(9):1187-90. PubMed ID: 5536794
    [No Abstract]   [Full Text] [Related]  

  • 55. Vertebrobasilar arterial insufficiency with dementia. Controlled trials of treatment with betahistine hydrochloride.
    Rivera VM; Meyer JS; Baer PE; Faibish GM; Mathew NT; Hartmann A
    J Am Geriatr Soc; 1974 Sep; 22(9):397-406. PubMed ID: 4212512
    [No Abstract]   [Full Text] [Related]  

  • 56. [Correlations between reactive hyperemia and response to vasodilator agents in patients with obliterating arteriopathies of the lower limbs].
    Dabizzi RP; Fantini F; Cappelli G; Grandonico F
    Minerva Cardioangiol; 1970 May; 18(5):287-90. PubMed ID: 5515012
    [No Abstract]   [Full Text] [Related]  

  • 57. The action of tetranicotinoylfructose in peripheral vascular disease.
    Andrews G; Judge TG; Walkey F
    Practitioner; 1973 Jul; 211(261):83-5. PubMed ID: 4580277
    [No Abstract]   [Full Text] [Related]  

  • 58. [Cerebral circulatory improvers and metabolic activators].
    Otomo E
    No To Shinkei; 1994 Mar; 46(3):239-44. PubMed ID: 8192938
    [No Abstract]   [Full Text] [Related]  

  • 59. Studies on the effect of alpha- and of beta-adrenergic blocking agents on the circulation in human limbs.
    Clement DL
    Verh K Acad Geneeskd Belg; 1980; 42(3-4):164-214. PubMed ID: 6114601
    [No Abstract]   [Full Text] [Related]  

  • 60. [Treatment by medicine which improves cerebral circulation and metabolism].
    Katsumata T; Katayama Y
    Nihon Rinsho; 2006 Nov; 64 Suppl 8():81-4. PubMed ID: 17469538
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.